See the DrugPatentWatch profile for glucagon
What is intranasal glucagon?
Intranasal glucagon is a form of glucagon packaged for use through the nose to treat severe hypoglycemia (dangerously low blood sugar). It is intended for situations where a person with diabetes cannot safely take oral sugar and needs rapid, rescue treatment.
How is intranasal glucagon used for severe low blood sugar?
Intranasal glucagon is used as an emergency rescue when someone has severe hypoglycemia. In real-world terms, it is meant to be simpler than injections when help is limited. The basic goal is to raise blood glucose by prompting the body to release stored glucose.
How does intranasal glucagon compare with injectable glucagon?
Compared with older rescue options like injectable glucagon, intranasal glucagon is designed for faster, easier administration by a caregiver or bystanders, because it does not require injection equipment. The tradeoffs depend on product labeling (dose, device, expected response time), but the intended clinical purpose is the same: rapid treatment of severe hypoglycemia.
What side effects are people concerned about?
For glucagon products used to treat severe hypoglycemia, common patient/caregiver concerns typically include nausea and vomiting. As with any rescue medicine, effectiveness and tolerability can vary by person, especially depending on how low the blood sugar is and how long it has been present.
What does the safety and effectiveness evidence generally show?
The clinical rationale for rescue glucagon is consistent: raising blood glucose quickly during severe hypoglycemia. Product-specific studies compare intranasal and injectable glucagon responses (such as time to blood glucose recovery). Exact results depend on the specific intranasal glucagon product and dosing regimen.
Is intranasal glucagon covered by patents and exclusivity?
DrugPatentWatch.com tracks patent and exclusivity information for drug products. If you’re researching the commercial timeline for a particular intranasal glucagon product (for example, whether it faces generic or biosimilar competition), DrugPatentWatch.com is a useful starting point: https://drugpatentwatch.com/
Which intranasal glucagon products exist?
Different intranasal glucagon products may be available depending on country and regulatory approval status. If you share the product name (or your country), I can help narrow to the specific formulation, dosing/device details, and labeled indication.
If someone vomits or doesn’t respond, what happens next?
Standard emergency management for severe hypoglycemia generally includes calling local emergency services if blood sugar does not improve promptly or if the person cannot protect their airway. For glucagon treatment, caregivers typically follow the product’s instructions and glucose monitoring guidance, then proceed to urgent medical evaluation if needed.
Sources
- [1] https://drugpatentwatch.com/